H.C. Wainwright reduces Reviva shares target following new share issuance
RVPH Stock | USD 1.90 0.11 5.47% |
Under 62% of Reviva Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Reviva Pharmaceuticals Holdings stock suggests that many investors are alarmed at this time. Reviva Pharmaceuticals' investing sentiment shows overall attitude of investors towards Reviva Pharmaceuticals Holdings.
Reviva |
H.C. Wainwright reduces Reviva shares target following new share issuance
Read at investing.com
Reviva Pharmaceuticals Fundamental Analysis
We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Reviva Pharmaceuticals is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Reviva Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Reviva Pharmaceuticals Related Equities
CUE | Cue Biopharma | 27.52 | ||||
ZVSA | ZyVersa Therapeutics | 13.76 | ||||
LTRN | Lantern Pharma | 13.33 | ||||
PLX | Protalix Biotherapeutics | 7.61 | ||||
FBIO | Fortress Biotech | 5.19 | ||||
ATHA | Athira Pharma | 3.64 | ||||
INAB | In8bio | 3.57 | ||||
CABA | Cabaletta Bio | 3.00 | ||||
EYPT | Eyepoint Pharmaceuticals | 2.86 | ||||
SLS | Sellas Life | 0.93 | ||||
UNCY | Unicycive Therapeutics | 1.27 | ||||
ACAD | ACADIA Pharmaceuticals | 1.34 |
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |